Uterine Papillary Serous, Clear Cell, and Poorly Differentiated Endometrioid Carcinomas A Comparative Study

被引:34
作者
Greggi, Stefano [1 ]
Mangili, Giorgia [2 ]
Scaffa, Cono [1 ]
Scala, Felice [1 ]
Losito, Simona [1 ]
Iodice, Francesco [1 ]
Pisano, Carmela [1 ]
Montoli, Serena [2 ]
Vigano, Riccardo [2 ]
Pirozzi, Giuseppe [1 ]
Giannarelli, Diana [3 ]
机构
[1] Ist Nazl Tumori G Pascale, Naples, Italy
[2] Ist Sci San Raffaele, Milan, Italy
[3] Ist Nazl Tumori Regina Elena, Med Data Ctr, Rome, Italy
关键词
Uterine papillary serous; Clear cell; Endometrioid carcinoma; CORPUS UTERI; CANCER; PROGNOSIS; EMPHASIS; PLOIDY; TUMORS;
D O I
10.1097/IGC.0b013e3182150c89
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Uterine papillary serous and clear cell carcinomas (UPSCs/CCs) show a different spreading from that of poorly differentiated endometrioid carcinomas (PDECs) and are usually thought to be prognostically more aggressive than PDECs. On the contrary, it has been recently claimed that UPSC/CC and PDEC have a similar prognosis. In this retrospective study on 2 institutional databases, the surgical-pathological data and survival have been compared in patients with UPSC/CC and PDEC. Methods: A total of 139 surgically staged consecutive patients, 63 with UPSC/CC (37 UPSC; 26 CC) and 76 with PDEC clinically limited to the uterine corpus, have been compared for nuclear ploidy, myometrial invasion, (occult) cervical extension, peritoneal, and lymph node metastasis. Prognostic factors have been correlated through multivariate analysis with survival (disease-specific [DSS] and disease-free [DFS]). Results: Peritoneal metastases and aneuploidy were found to be the only parameters significantly different in the 2 groups: peritoneal metastases 28.6% in UPSC/CC (extrapelvic 19%) and 7.9% in PDEC (extrapelvic 2.6%) (P = 0.001), aneuploidy 48.6% in UPSC/CC and 30.6% in PDEC (P = 0.05). Five-year DSS was 57.9% versus 75.2% (P = 0.02), and DFS was 52.3% versus 71.4% (P = 0.04) for UPSC/CC and PDEC, respectively. All but cervical and lymph node involvement were significant predictors of survival. After multivariate analysis, histotype (DSS: hazard ratio [HR], 1.98; 95% confidence interval [CI], 1.02-3.86; P = 0.04; DFS: HR, 1.94; 95% CI, 1.04-3.63; P = 0.04), stage (DSS: HR, 2.26; 95% CI, 1.10-4.65; P = 0.03; DFS: HR, 2.21; 95% CI, 1.12-4.38; P = 0.02), and myometrial invasion (DSS: HR, 2.86; 95% CI, 1.22-6.69; P = 0.01; DFS: HR, 3.96; 95% CI, 1.63-9.62; P = 0.002) were independent risk factors for survival. Conclusions: Uterine papillary serous and clear cell carcinomas spread to abdominal peritoneum more frequently than PDEC; multivariate analysis confirms UPSC/CC as an independent, unfavorable predictor of outcome.
引用
收藏
页码:661 / 667
页数:7
相关论文
共 28 条
[1]  
ABELER UA, 1992, CANCER-AM CANCER SOC, V69, P488
[2]  
Abeler VM, 1996, CANCER, V78, P1740, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1740::AID-CNCR14>3.0.CO
[3]  
2-Y
[4]   Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer? [J].
Alektiar, KM ;
McKee, A ;
Lin, O ;
Venkatraman, E ;
Zelefsky, MJ ;
McKee, B ;
Hoskins, WJ ;
Barakat, RR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (01) :79-85
[5]   Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in International Federation of Gynecology and Obstetrics stage 1 and 2 endometrial carcinoma [J].
Baak, JPA ;
Snijders, W ;
van Diermen, B ;
van Diest, PJ ;
Diepenhorst, FW ;
Benraadt, J .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (22) :4214-4221
[6]   Uterine serous and Grade 3 endometrioid carcinomas - Is there a survival difference? [J].
Boruta, DM ;
Gehrig, PA ;
Groben, PA ;
Bae-Jump, V ;
Boggess, JF ;
Fowler, WC ;
Van Le, L .
CANCER, 2004, 101 (10) :2214-2221
[7]   Geographic and temporal variations in cancer of the corpus uteri: Incidence and mortality in pre- and postmenopausal women in Europe [J].
Bray, F ;
Loos, AH ;
Oostindier, M ;
Weiderpass, E .
INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (01) :123-131
[8]   UTERINE PAPILLARY SEROUS CARCINOMA - A STUDY ON 108 CASES WITH EMPHASIS ON THE PROGNOSTIC-SIGNIFICANCE OF ASSOCIATED ENDOMETRIOID CARCINOMA, ABSENCE OF INVASION, AND CONCOMITANT OVARIAN-CARCINOMA [J].
CARCANGIU, ML ;
CHAMBERS, JT .
GYNECOLOGIC ONCOLOGY, 1992, 47 (03) :298-305
[9]   The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma [J].
Cirisano, FD ;
Robboy, SJ ;
Dodge, RK ;
Bentley, RC ;
Krigman, HR ;
Synan, IS ;
Soper, JT ;
Clarke-Pearson, DL .
GYNECOLOGIC ONCOLOGY, 2000, 77 (01) :55-65
[10]   Non-endometrioid carcinomas of the uterine corpus: A review of their pathology with emphasis on recent advances and problematic aspects [J].
Clement, PB ;
Young, RH .
ADVANCES IN ANATOMIC PATHOLOGY, 2004, 11 (03) :117-142